Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04896060 · ClinicalTrials.gov registry record

The Impact of the COVID-19 Pandemic on Eating Behavior and Weight Change

A clinical trial, sponsored by National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK).

Completed
Registry status
5,056
Enrollment target

NCT04896060 is a clinical trial that has completed, run by National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK). The registered enrollment target is 5,056 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04896060 has completed, sponsored by National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK).

COMPLETED
Registry status
5,056 participants
Enrollment target

Study Summary

Background: The indirect effects of the COVID-19 pandemic on mental health are of increasing concern. Perceived stress can lead to binge eating and weight gain. Researchers want to learn more about the relationship between eating behavior and the pandemic. Objective: To study how the stress of the COVID-19 pandemic is affecting eating behaviors and weight. Eligibility: English-speaking adults ages 18 and older who have access to a computer or smartphone connected to the internet. Design: This is an online study. Participants will answer surveys through the study website. Participants will complete a one-time survey. It will ask about their experiences throughout the COVID-19 pandemic, their socioeconomic standing, their mental and physical health, and their eating habits. They will have the option to repeat the survey once a month for the next 12 months. This will show changes in their thoughts and behaviors over time. They will provide their email address to get survey links. Participants will also have the option to complete a 2-minute survey on their smartphone. They will complete the survey daily for 7 days in a row. It will ask about their stress and eating behavior in real time, in their home environment. They will provide their phone number to get survey links via text message. If a participant has taken part in a previous NIH study on the Phoenix AZ campus, they will be asked to share their first and last name, date of birth, and email address. This information will be used to connect data from this study to their past data. Participation is typically 25 minutes but may last up to 1 year. \*\*\*To participate in this study go to the REDCap study link: https://redcap.link/nihcovidstudy.\*\*\*...

Trial Details

FieldValue
Enrollment Target 5,056 participants
Start Date 2022-09-01
Est. Completion 2025-02-13

What the Registry Record Tells You About NCT04896060

The ClinicalTrials.gov registry entry for NCT04896060 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 5,056 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), which has 490 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 0 interventions.

NCT04896060 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT04896060 about?

NCT04896060 is a clinical study titled "The Impact of the COVID-19 Pandemic on Eating Behavior and Weight Change". Background: The indirect effects of the COVID-19 pandemic on mental health are of increasing concern. Perceived stress can lead to binge eating and weight gain. Researchers want to learn more about the relationship between eating behavior and the pandemic. Objective: To study how the stress of th...

What is the current status of trial NCT04896060?

This trial is currently completed. The enrollment target is 5,056 participants. The study started on 2022-09-01. Estimated completion is 2025-02-13.

Who is sponsoring clinical trial NCT04896060?

This trial is sponsored by National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), which has 490 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.